HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2017-08-31
2016-08-31
Total Revenue
257.099
257.099
88.763
25.943
0
0
Cost of Revenue
2,664
2,664
-
-
-
-
Gross Profit
-2,407
-2,407
-
-
-
-
Operating Expenses
Selling General and Administrative
29,863
29,863
24,779
3,550
24.45
38.786
Total Operating Expenses
33,935
33,935
25,364
3,550
24.45
38.786
Operating Income or Loss
-36,342
-36,342
-25,275
-3,525
-24.45
-38.786
Interest Expense
206.454
206.454
-
-
-
-
Total Other Income/Expenses Net
-15,465
-15,465
2,565
-
-
-
Income Before Tax
-52,013
-52,013
-22,711
-3,525
-24.45
-38.786
Income from Continuing Operations
-52,013
-52,013
-22,711
-3,525
-24.45
-38.786
Net Income
-52,013
-52,013
-22,711
-3,525
-24.45
-38.786
Net Income available to common shareholders
-52,013
-52,013
-22,711
-3,525
-24.45
-38.786
Basic EPS
-
-7.37
-3.82
-0.54
-0.00
-0.01
Diluted EPS
-
-7.37
-3.82
-0.54
-0.00
-0.01
Basic Average Shares
-
7,056
5,905
6,565
6,565
6,565
Diluted Average Shares
-
7,056
5,905
6,565
6,565
6,565
EBITDA
-
-48,660
-25,092
-3,525
-24.45
-38.786